According to a new study, the topical corticosteroid medication lyme disease cream and the antibiotic fomitiflorin can be used to treat acne spot problems and other skin conditions.
A new study from The Journal of Cosmetic Dermatology, a peer-reviewed journal, has shown that a topical corticoquinolone cream and a topical fomiticorin gel can prevent acne spots and other signs of inflammation.
The study was conducted by a team of dermatologists and skin care experts from the University of California, San Diego.
They used the latest research to determine the best and most effective way to treat patients with acne or acne-related conditions.
The findings could be important for patients who have difficulty getting the proper treatment or those who are not using the right treatment due to cost.
According to the study, acne patients who received the topical fomeitifolorin cream and topical cortisone cream reported lower numbers of breakouts, more manageable skin, less redness, and less flaking than patients who used the non-comedogenic gel.
The authors wrote that the results showed that the topical formulation could be used safely and effectively to treat the signs of acne.
“Our findings suggest that the fomeitalin cream is most effective for treating acne associated with inflammatory conditions such as inflammatory nodular hyperpigmentation, eczema, and rosacea,” they wrote.
“Fomeitifflorin gel is effective for acne associated dermatitis, including atopic dermatitis and inflammatory nodularity.”
The study is one of the first to examine the effectiveness of a topical steroid cream and cream for the prevention of acne, they said.
They said there are currently no studies that have evaluated the efficacy of topical corticolin cream.
According the authors, the effectiveness was similar for both topical cortesone cream (an antiseptic agent) and topical lyme-DDR-16 gel (a medication that can be absorbed through the skin).
The topical cortexin cream was found to be more effective for patients with eczematous acne and psoriasis than the topical lymes-DRA-16 cream.
The researchers noted that the cream used in the study had a longer half-life than the cream containing the steroid, which could be a reason for the shorter duration of effectiveness.
Lyme-DR-12 cream and lymes dreum, a steroid, have a shorter half-lives than topical cortisol.
A second study, published in the American Journal of Dermatologic Surgery, also revealed that patients who were treated with the fomiteiflorins cream and fomitingorin Gel had fewer skin lesions and flaking.
The studies were performed at the Mayo Clinic in Rochester, Minnesota, and the University College of London in London.
The team, led by Dr. Mark Kramm, professor of dermatology at the University at Buffalo Medical Center, and Dr. David McEwen, an associate professor at the medical school, studied patients who had acne-associated dermatitis.
Dr. Krams study found that patients with inflammatory acne had significantly more flare-ups and less red skin than those with non-inflammatory acne.
Dr McEwens study found a higher number of acne breakouts in patients who took the topical Lyme-DL-16 and Lyme DR-12 creams.
Both drugs were effective in treating acne.
However, they did not help to prevent the appearance of the flaking or breakouts that can occur when topical steroids and creams are applied to the skin.
“We were concerned about the long-term effects of this medication on the skin, especially for those patients with chronic inflammatory conditions who had failed to respond to other treatment options,” Dr McEwan said.
“We thought the longer half lives of the topical steroids could be problematic.”
Dr McElwee said it was important to know whether patients who take these topical steroids are at higher risk of developing an allergic reaction or other adverse reactions.
“There is no evidence that topical cortics are more likely to cause an allergic response than other steroid medications,” he said.
“The question remains: Are these patients more likely than other patients to develop adverse reactions, or is this simply due to their existing inflammatory conditions?”
Dr McEllwans research team also found that the gel formulations were effective for preventing breakouts.
The investigators noted that they were interested in studying the effectiveness and safety of the treatment of patients with moderate or severe acne.
They wrote that they wanted to know how well the treatment worked and how long it lasted for.
Follow CBSMIAMI.COM: Facebook | Twitter | Instagram